EUCTR2012-004285-18-FI进行中（未招募）1 期
The pain relieving effect of nitrous oxide during bone marrow aspiration and biopsy - a placebo-controlled and randomized trial
Helsingin yliopisto0 个研究点目标入组 70 人开始时间: 2012年10月10日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •adult patients with known or suspected hematological disease undergoing bone marrow aspiration and biopsy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 70
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 70
排除标准
- •-allergy to lidocaine
- •-body mass index over 32 kg/m2
- •-unstable angina pectoris
- •-pregnancy
- •-emphysema/COPD
- •-dementia/Alzheimer's disease
研究者
相似试验
已完成
不适用
Validation of analgesic effect of nitrous oxide in neonates and infantsISRCTN71821503Department of Health270
进行中（未招募）
1 期
SE OF THE ANESTHETIC NITROUS OXIDE FOR PAIN RELIEF IN DIFFERENT PROCEDURES IN GYNECOLOGYPain associated to hysteroscopy proceduresEUCTR2013-005426-30-ESFUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS
进行中（未招募）
1 期
Quantification of the anesthetic effect of nitrous oxide using intravenous closed-loop anesthesia - Lachgas Closed loopThis is a study of the anesthetic effect of the IMP, nitrous oxide. In this sense general anesthesia can be termed the medical condition under investigation.EUCTR2007-001677-28-DECharité - Universitätsmedizin Berlin180
尚未招募
不适用
A Study to assess role of Nitrous Oxide Anaesthesia on graft uptake in Tympanoplasty surgery in children.CTRI/2020/05/025003ady Hardinge Medical College
进行中（未招募）
不适用
The Effects of Nitric Oxide for Inhalation during Left Ventricular Assist Device (LVAD)Implantation. - INOT41acute right ventricular failureMedDRA version: 9.1Level: LLTClassification code 10063082Term: Acute right ventricular failureEUCTR2005-000326-24-DEINO Therapeutics110